Spinocerebellar ataxias (SCAs) are neurodegenerative disorders characterized by predominant atrophy of the cerebellum and pons, with the main symptom being ataxia. There is currently no treatment for this disorder due to the lack of robust biomarkers to evaluate the disease progression. This study aimed to identify robust biomarkers for this disorder using a combination of magnetic resonance spectroscopy and imaging techniques. This study confirmed neurometabolic alterations in SCAs as well as microstructural modifications resulting from the disease. This study also showed that imaging biomarkers are more sensitive to disease progression than clinical scores.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords